Mallinckrodt plc (OTCMKTS: MNKPF), a UK-based global specialty pharmaceutical company, announced on Monday that it has named Lisa French as its new executive vice president and chief commercial officer, effective 1 October 2022.

In the new role, French is to manage the development and implementation of the company's commercialisation strategy. She will serve on the executive committee and will succeed Hugh O'Neill.

French has over 30 years of commercial biopharmaceutical experience. She has headed the United States Women's Health Commercial team for Organon & Co and held various roles of increasing responsibility at Merck.